Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028) †

Background: With anti-inflammatory properties, cannabinoids may be a potential strategy to reduce immune activation in people living with HIV (PLWH) but more information on their safety and tolerability is needed. Methods: We conducted an open-label interventional pilot study at the McGill Universit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mboumba Bouassa, Ralph-Sydney, Needham, Judy, Nohynek, Dana, Singer, Joel, Lee, Terry, Bobeuf, Florian, Samarani, Suzanne, Del Balso, Lina, Paisible, Natalie, Vertzagias, Claude, Sebastiani, Giada, Margolese, Shari, Mandarino, Enrico, Klein, Marina, Lebouché, Bertrand, Cox, Joseph, Brouillette, Marie-Josée, Routy, Jean-Pierre, Szabo, Jason, Thomas, Réjean, Huchet, Emmanuel, Vigano, Antonio, Jenabian, Mohammad-Ali, Costiniuk, Cecilia T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775551/
https://www.ncbi.nlm.nih.gov/pubmed/36551926
http://dx.doi.org/10.3390/biomedicines10123168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775551/
https://www.ncbi.nlm.nih.gov/pubmed/36551926
http://dx.doi.org/10.3390/biomedicines10123168

Ejemplares similares